p21-activated kinase 1 (PAK1) can promote ERK activation in a kinase-independent manner

Zhipeng Wang1, Meng Fu, Lifeng Wang

  • 1Key Laboratory of Gastrointestinal Pharmacology of Chinese Materia Medica of the State Administration of Traditional Chinese Medicine, Department of Pharmacology, School of Pharmacy, Fourth Military Medical University, Xi'an 710032, China.

Insights

p21-activated kinase 1 (PAK1) promotes cell proliferation and tumorigenesis. PAK1 can stimulate MEK activity independently of its kinase function, likely by scaffolding C-RAF interactions.

Area of Science:

  • Cellular signaling pathways
  • Cancer biology
  • Protein kinase regulation

Background:

  • p21-activated kinase 1 (PAK1) is implicated in cell proliferation and tumorigenesis.
  • PAK1's role in regulating the ERK/MAPK pathway, particularly through C-RAF and MEK1, is crucial.

Purpose of the Study:

  • To investigate the kinase-dependent and independent mechanisms by which PAK1 influences MEK/ERK signaling.
  • To elucidate the role of PAK1 as a scaffold in regulating C-RAF and MEK1 interactions.

Main Methods:

  • Utilized kinase-dead PAK1 mutants to assess kinase-dependent signaling.
  • Investigated the formation of protein complexes using PAK1 activators like Rac1.
  • Analyzed phosphorylation levels of key signaling proteins including MEK1/2, ERK, B-RAF, and C-RAF.

Main Results:

  • Overexpression of kinase-dead PAK1 increased MEK1/2 and ERK phosphorylation, while C-RAF and B-RAF phosphorylation remained unchanged.
  • Activation of Rac1 led to a Rac1-PAK1-MEK1 complex formation independent of PAK1's kinase activity.
  • These findings suggest PAK1 acts as a scaffold, facilitating C-RAF interactions to stimulate MEK activity.

Conclusions:

  • PAK1 regulates MEK activity through both kinase-dependent and kinase-independent mechanisms.
  • PAK1's scaffolding function is critical for its ability to modulate MEK/ERK signaling independently of its enzymatic activity.
  • These insights into PAK1 signaling offer potential therapeutic targets for cancer treatment.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...